Share on StockTwits

ADMA Biologics (NASDAQ:ADMA) CEO Adam S. Grossman bought 2,100 shares of ADMA Biologics stock in a transaction dated Thursday, August 14th. The shares were purchased at an average price of $9.77 per share, for a total transaction of $20,517.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Shares of ADMA Biologics (NASDAQ:ADMA) opened at 9.77 on Friday. ADMA Biologics has a one year low of $6.52 and a one year high of $10.75. The stock’s 50-day moving average is $9.9 and its 200-day moving average is $8.82. The company’s market cap is $90.8 million.

Separately, analysts at Maxim Group reiterated a “buy” rating on shares of ADMA Biologics in a research note on Friday, July 11th. They now have a $15.00 price target on the stock.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.